News
Kazia Therapeutics Says Nasdaq Determined That Company Is Eligible For Additional 180 Calendar Day Period, Or Until November 18, 2024 To Regain Compliance
23 May 24
News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
21 May 24
Movers
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
12 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
5 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Press releases
Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement
23 May 24
Press Releases
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
1 May 24
Press Releases
Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases
21 Mar 24
Press Releases
Kazia announces presentation of new data at AACR Annual Meeting
13 Mar 24
Press Releases